JNP discloses three pipeline applications of intra-vaginal ring: http://finance.yahoo.com/news/juniper-pharmaceuticals-adds-three-products-142000974.html• JNP-0101, an oxybutynin IVR for the treatment of overactive bladder; • JNP-0201, a combination IVR delivering estrogen and progesterone hormone replacement therapy (HRT); and, • JNP-0301, a progesterone IVR for the prevention of preterm birth. More details in the PR. Comments?